Adding low-dose spironolactone to multidrug regimens for resistant hypertension.

Current hypertension reports

Volumn 6, Issue 3, 2004, Pages 211-212

  Berecek, Kathleen H ^a   Farag, Amal ^a   Bahtiyar, Gul ^a   Rothman, Jeffery ^a   McFarlane, Sammy I ^a  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALDOSTERONE ANTAGONIST; ANGIOTENSIN RECEPTOR; ANTIHYPERTENSIVE AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; SPIRONOLACTONE;

ARTICLE; BLOOD PRESSURE; DIASTOLE; DOSE RESPONSE; DRUG ANTAGONISM; DRUG COMBINATION; DRUG EFFECT; HUMAN; HYPERTENSION; PATHOPHYSIOLOGY; SYSTOLE;

ALDOSTERONE ANTAGONISTS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANTIHYPERTENSIVE AGENTS; BLOOD PRESSURE; DIASTOLE; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG THERAPY, COMBINATION; HUMANS; HYPERTENSION; RECEPTORS, ANGIOTENSIN; SPIRONOLACTONE; SYSTOLE;

MLCS; MLOWN;

EID: 4644291439     PISSN: 15226417     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11906-004-0071-z     Document Type: Article

References (0)